-
公开(公告)号：US20240082259A1
公开(公告)日：2024-03-14
申请号：US18507884
申请日：2023-11-13
发明人： Paul Sudhakar , Scott Boyer
IPC分类号： A61K31/554 , A61K9/00 , A61K9/14 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/24 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/38 , A61P25/18
CPC分类号： A61K31/554 , A61K9/0053 , A61K9/14 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/24 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/38 , A61P25/18
摘要： The present invention provides for an oral liquid suspension that includes quetiapine or a pharmaceutically acceptable salt thereof. Also provided is a method for orally delivering quetiapine fumarate to a subject (e.g., for treating a mental disorder in a subject, such as schizophrenia, bipolar mania, and/or bipolar depression). The method includes orally administering to the subject an oral liquid suspension described herein.
-
公开(公告)号：US11813269B2
公开(公告)日：2023-11-14
申请号：US17362432
申请日：2021-06-29
发明人： Paul Sudhakar , Scott Boyer
IPC分类号： A61K31/554 , A61K47/14 , A61K47/12 , A61K47/26 , A61K47/24 , A61P25/18 , A61K47/38 , A61K47/36 , A61K47/34 , A61K9/00 , A61K9/14 , A61K47/10
CPC分类号： A61K31/554 , A61K9/0053 , A61K9/14 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/24 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/38 , A61P25/18
摘要： The present invention provides for an oral liquid suspension that includes quetiapine or a pharmaceutically acceptable salt thereof. Also provided is a method for orally delivering quetiapine fumarate to a subject (e.g., for treating a mental disorder in a subject, such as schizophrenia, bipolar mania, and/or bipolar depression). The method includes orally administering to the subject an oral liquid suspension described herein.
-
公开(公告)号：US20210121477A1
公开(公告)日：2021-04-29
申请号：US17083497
申请日：2020-10-29
发明人： Paul Sudhakar , Scott Boyer
IPC分类号： A61K31/554 , A61K9/00 , A61K47/14 , A61K47/26 , A61K47/24 , A61P25/18 , A61K47/36 , A61K47/34 , A61K47/38 , A61K9/14 , A61K47/12 , A61K47/10
摘要： The present invention provides for an oral liquid suspension that includes quetiapine or a pharmaceutically acceptable salt thereof. Also provided is a method for orally delivering quetiapine fumarate to a subject (e.g., for treating a mental disorder in a subject, such as schizophrenia, bipolar mania, and/or bipolar depression). The method includes orally administering to the subject an oral liquid suspension described herein.
-
公开(公告)号：US11612566B2
公开(公告)日：2023-03-28
申请号：US16951400
申请日：2020-11-18
发明人： Paul Sudhakar , Scott Boyer
IPC分类号： A61K9/10 , A61K31/53 , A61K9/00 , A61K47/10 , A61K47/02 , A61K47/26 , A61K47/22 , A61K47/36 , A61K47/38 , A61K47/14
摘要： The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
-
公开(公告)号：US11596634B2
公开(公告)日：2023-03-07
申请号：US15929929
申请日：2020-05-29
发明人： Paul Sudhakar , Scott Boyer
IPC分类号： A61K31/53 , A61K47/06 , A61K47/10 , A61K9/00 , A61K47/26 , A61K47/38 , A61K47/36 , A61K47/02 , A61K47/34
摘要： The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
-
公开(公告)号：US20210069107A1
公开(公告)日：2021-03-11
申请号：US16951869
申请日：2020-11-18
发明人： Paul Sudhakar , Scott Boyer
IPC分类号： A61K9/00 , A61K31/7048 , A61K47/10 , A61K47/14 , A61K47/12 , A61K47/36 , A61K47/38 , A61K47/02 , A61K9/10
摘要： Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
-
公开(公告)号：US20240342183A1
公开(公告)日：2024-10-17
申请号：US18752293
申请日：2024-06-24
发明人： Paul Sudhakar , Scott Boyer
IPC分类号： A61K31/53 , A61K9/00 , A61K47/02 , A61K47/06 , A61K47/10 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/38
CPC分类号： A61K31/53 , A61K9/0053 , A61K47/02 , A61K47/06 , A61K47/10 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/38
摘要： The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
-
公开(公告)号：US20240173315A1
公开(公告)日：2024-05-30
申请号：US18508992
申请日：2023-11-14
发明人： Paul Sudhakar , Scott Boyer
IPC分类号： A61K31/496 , A61K9/00 , A61K9/08 , A61K47/12 , A61K47/14 , A61K47/18 , A61K47/22 , A61K47/26 , A61K47/46
CPC分类号： A61K31/496 , A61K9/0053 , A61K9/08 , A61K47/12 , A61K47/14 , A61K47/183 , A61K47/22 , A61K47/26 , A61K47/46
摘要： The present invention provides for an oral solution containing trazodone, methods of manufacturing the same, and methods of using the same, e.g., to treat major depressive disorder (MDD).
-
公开(公告)号：US20230414503A1
公开(公告)日：2023-12-28
申请号：US18462651
申请日：2023-09-07
发明人： Paul Sudhakar , Scott Boyer
摘要： Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
-
公开(公告)号：US20220096378A1
公开(公告)日：2022-03-31
申请号：US17643818
申请日：2021-12-10
发明人： Paul Sudhakar , Scott Boyer
摘要： Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
-
-
-
-
-
-
-
-
-
搜索结果
19 条记录 (耗时 0.012 秒)
